Commentaries, editorials and guidance documents
The publications listed below are personal or institutional views on the choice between EQ-5D-3L and EQ-5D-5L. These were published as commentaries, editorials or guidance documents.
| Study Title | First Author | Journal | Year | Type |
|---|---|---|---|---|
| Position statement on use of the EQ-5D-5L valuation set | National Institute for Health and Care Excellence | 2019 | policy document | |
| 3L, 5L, What the L? A NICE Conundrum | Devlin N | Pharmacoeconomics | 2018 | editorial |
| EQ-5D-5L: Smaller steps but a major step change? | Brazier J | Health Economics | 2018 | editorial |
| Once Bitten Twice Shy: Thinking Carefully Before Adopting the EQ-5D-5L | Round J | Pharmacoeconomics | 2018 | editorial |
| EQ-5D: Moving from Three Levels to Five | Lloyd A | Value in Health | 2018 | editorial |
| Bad reasons not to use the EQ-5D-5L | Sampson C | The Academic Health Economists’ Blog | 2018 | commentary |
| Guideline for economic evaluations in health care | Zorginstituut Nederland | 2016 | policy document |
(Version 24OCT2019)